Evaluation of the Global Auditory Nerve Activity for Exploration of Hearing in Humans

NCT ID: NCT03552224

Last Updated: 2021-12-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-07-11

Study Completion Date

2021-06-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To date, all the electrophysiological methods for auditory testing rely on the measure on synchronous evoked auditory nerve activity. This measure only takes into account the response of the first action potential in every auditory fibber, but provides no information about the neural response during a sustained activity. This can explain why in experimental models, a loss of more of 80% of auditory nerve fibbers cannot be detected by usual electrophysiological measurements. In this study we aim at investigating the global spontaneous and sound evoked auditory nerve activity by recording directly the electrical field by an electrode placed directly on the auditory nerve of subjects during a skull base surgical procedure. We expected to demonstrated differences in the electrical activity between subjects with or without hearing loss.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hearing Loss

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Evoked auditory nerve activity Hearing Loss Tinnitus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Subjects with no hearing loss

Subjects referred for cerebellopontine angle surgery with no hearing loss with recording of auditory nerve activity by contact electrode

Group Type EXPERIMENTAL

Recording of auditory nerve activity

Intervention Type PROCEDURE

near field recording of auditory nerve activity with contact electrode

Subjects with hearing loss

Subjects referred for cerebellopontine angle surgery with hearing loss with recording of auditory nerve activity by contact electrode

Group Type EXPERIMENTAL

Recording of auditory nerve activity

Intervention Type PROCEDURE

near field recording of auditory nerve activity with contact electrode

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Recording of auditory nerve activity

near field recording of auditory nerve activity with contact electrode

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 - 80 years ( inclusive borders)
* patient having to undergo surgery at the level of the ponto-cerebellar angle (microvascular decompression, vestibular neurotomy, tumor resection of the meningioma type or schwannoma) and
* Unaffected by neuro-sensory hearing loss, defined by mean auditory thresholds of less than 20 dB in tone audiometry in bone conduction on the side of the ear to be operated (N = 15, Group 1) or
* Showing mild to moderate hearing loss defined by average hearing loss (average of 500, 1000, 2000 and 4000 Hz thresholds) greater than 20 dB and less than 55 dB in air conduction threshold tone audiometry (N = 15 Group 2).
* Voluntary subjects to participate in the study,
* Subjects having signed written consent to participate in the study,
* Easily accessible topics.

Exclusion Criteria

* Subjects unable to understand the nature and goals of the study and / or having difficulty communicating with the investigator,
* Subjects refusing to participate, subjects whose free and informed consent has not been sought, subjects for which a consent form has not been signed,
* Subjects for whom there is a contraindication to general anesthesia,
* Subjects with a central neurological pathology that can disrupt electrophysiological recordings
* Not affiliated to a French social security scheme or not benefiting from such a scheme,
* Majors protected by law,
* Pregnant women,
* deprived of liberty by judicial or administrative decision,
* Infectious or inflammatory pathology of the middle ear.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institute for Neurosciences of Montpellier U1051

UNKNOWN

Sponsor Role collaborator

Reims University hospital

OTHER

Sponsor Role collaborator

University Hospital, Montpellier

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Frédéric VENAIL, PU-PH

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Montpellier

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Montpellier

Montpellier, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

9890

Identifier Type: -

Identifier Source: org_study_id